Diabetes and Endocrine Disorders

Diabetes and Aging

Submit Abstract Register Now

Diabetes is becoming one of the most common health problems among the elderly. The global prevalence of diabetes in people over the age of 65 was 123 million in 2017 and is expected to double by 2045. Elderly patients with diabetes are at increased risk of common senile syndrome, including frailty, cognitive impairment and dementia, urinary incontinence, traumatic falls and fractures, disorders, and polypharmacy side effects, which have important impacts on quality of life. With all these factors, clinical management of type 2 diabetes in older patients is now a real challenge for physicians, and in fact, the optimal glycaemic goals that older diabetic patients can achieve are still controversial. The American Diabetes Association has proposed a 6.5% HbA1c target for patients with serious illness and high risk of hypoglycaemia. In contrast, for older patients, the American College of Physicians (ACP) suggests a more conservative goal (HbA1c levels 7-8%) and weaker medications when HbA1C levels are 6.5%. I am. Glycaemic target management and anti-hyperglycaemic treatment need to be personalized based on medical history and comorbidities, and drugs with a low risk of hypoglycaemia are preferred.